Astellas\' Xtandi "significantly improves" progressionfree survival in advanced hormonesensitive prostate cancer httpbit.ly2dDrNlUÂ ProstateCancer cancer pharma AstellasUS

Astellas' Xtandi "significantly improves" progression-free survival in advanced hormone-sensitive prostate cancer http://bit.ly/2dDrNlU  #ProstateCancer #cancer #pharma @AstellasUS

13:30 EST 18 Feb 2019 | Pharmafile

Astellas' Xtandi "significantly improves" progression-free survival in advanced hormone-sensitive prostate cancer http://bit.ly/2dDrNlU  #ProstateCancer #cancer #pharma @AstellasUS

More From BioPortfolio on "Astellas' Xtandi "significantly improves" progression-free survival in advanced hormone-sensitive prostate cancer http://bit.ly/2dDrNlU  #ProstateCancer #cancer #pharma @AstellasUS"